MétaCan
Menu
Back to cohort
Record W2979548775 · doi:10.1136/bmjopen-2019-031092

Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial

2019· article· en· W2979548775 on OpenAlexafffundabout
Salma Shickh, Marc Clausen, Chloe Mighton, Mariana Salazar, Kathleen-Rose Zakoor, Rita Kodida, Emma Reble, Christine Elser, Andrea Eisen, Seema Panchal, Melyssa Aronson, Tracy Graham, Susan Randall Armel, Chantal F. Morel, Ramzi Fattouh, Emily Glogowski, Kasmintan A. Schrader, Jada G. Hamilton, Kenneth Offit, Mark E. Robson, June Carroll, Wanrudee Isaranuwatchai, Raymond H. Kim, Jordan Lerner‐Ellis, Kevin E. Thorpe, Andreas Laupacis, Yvonne Bombard

Bibliographic record

VenueBMJ Open · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGenomics and Rare Diseases
Canadian institutionsPublic Health OntarioUniversity of British ColumbiaBC Cancer AgencyMount Sinai HospitalLunenfeld-Tanenbaum Research InstitutePrincess Margaret Cancer CentreSt. Michael's HospitalSunnybrook Health Science CentreSinai Health SystemHealth Sciences CentreUniversity Health NetworkUniversity of Toronto
FundersNational Cancer InstituteCanadian Institutes of Health Research
KeywordsMedicineDistressClinical trialPopulationHealth careRandomized controlled trialGenetic testingFamily medicineMEDLINEIntervention (counseling)PsychiatryInternal medicineClinical psychologyEnvironmental health

Abstract

fetched live from OpenAlex

INTRODUCTION: Genomic sequencing has rapidly transitioned into clinical practice, improving diagnosis and treatment options for patients with hereditary disorders. However, large-scale implementation of genomic sequencing faces challenges, especially with regard to the return of incidental results, which refer to genetic variants uncovered during testing that are unrelated to the primary disease under investigation, but of potential clinical significance. High-quality evidence evaluating health outcomes and costs of receiving incidental results is critical for the adoption of genomic sequencing into clinical care and to understand the unintended consequences of adoption of genomic sequencing. We aim to evaluate the health outcomes and costs of receiving incidental results for patients undergoing genomic sequencing. METHODS AND ANALYSIS: We will compare health outcomes and costs of receiving, versus not receiving, incidental results for adult patients with cancer undergoing genomic sequencing in a mixed-methods randomised controlled trial. Two hundred and sixty patients who have previously undergone first or second-tier genetic testing for cancer and received uninformative results will be recruited from familial cancer clinics in Toronto, Ontario. Participants in both arms will receive cancer-related results. Participants in the intervention arm have the option to receive incidental results. Our primary outcome is psychological distress at 2 weeks following return of results. Secondary outcomes include behavioural consequences, clinical and personal utility assessed over the 12 months after results are returned and health service use and costs at 12 months and 5 years. A subset of participants and providers will complete qualitative interviews about utility of incidental results. ETHICS AND DISSEMINATION: This study has been approved by Clinical Trials Ontario Streamlined Research Ethics Review System that provides ethical review and oversight for multiple sites participating in the same clinical trial in Ontario.Results from the trial will be shared through stakeholder workshops, national and international conferences, and peer-reviewed journals. TRIAL REGISTRATION NUMBER: NCT03597165.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.071
metaresearch head score (Gemma)0.065
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.966
Threshold uncertainty score0.373

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0710.065
Meta-epidemiology (narrow)0.0090.004
Meta-epidemiology (broad)0.0120.012
Bibliometrics0.0040.005
Science and technology studies0.0050.006
Scholarly communication0.0070.004
Open science0.0050.002
Research integrity0.0090.008
Insufficient payload (model declined to judge)0.0720.009

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.047
GPT teacher head0.442
Teacher spread0.394 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations18
Published2019
Admission routes3
Has abstractyes

Explore more

Same venueBMJ OpenSame topicGenomics and Rare DiseasesFrench-language works237,207